Tesa.PNG

Tesamorelin 10mg

$80.00

Tesamorelin is not just another GH secretagogue, it’s a precision-engineered GHRH analogue that targets visceral fat, preserves hormonal balance, and may offer neuroprotective benefits.

Molecular Engineering

  • 44-amino acid GHRH analogue with N-terminal modifications

  • These tweaks enhance enzymatic stability, extend half-life, and optimize receptor binding

  • Unlike natural GHRH, tesamorelin resists degradation and maintains potency over time

Targeted Visceral Fat Reduction

  • Tesamorelin selectively reduces visceral adipose tissue (VAT)—the deep, inflammatory fat around organs

  • Clinical studies show 15-20% VAT reduction over 6 months, with minimal impact on subcutaneous fat

  • This selectivity is due to higher GH receptor density in visceral fat cells, making them more responsive to GH pulses

Feedback-Preserving GH Modulation

  • Stimulates endogenous GH release via pituitary GHRH receptors

  • Preserves natural feedback loops, unlike exogenous GH which suppresses native production

  • Elevates IGF-1 without overshooting physiological GH levels, reducing risk of insulin resistance

Emerging Neurocognitive Benefits

  • Tesamorelin has shown promise in improving cognitive function in HIV-positive individuals with abdominal obesity

  • May support hippocampal integrity and working memory, likely via IGF-1 and GH-mediated neurogenesis

Common Side Effects

  • Injection site reactions: Redness, swelling, or discomfort

  • Joint pain or stiffness: Especially in knees, wrists, or fingers

  • Muscle aches: Mild soreness or fatigue

  • Peripheral edema: Fluid retention in hands, feet, or face

  • Tingling or numbness: Often in fingers (carpal tunnel-like symptoms)

Less Common but Notable

  • Elevated fasting glucose: Tesamorelin may slightly raise blood sugar in some individuals

  • Headache, dizziness, or palpitations: Usually transient

  • Nervousness or sleep disturbances: Rare but reported

  • Hypersensitivity reactions: Rash, hives, or swelling, discontinue if observed

Cautionary Notes

  • Pregnancy: Tesamorelin can harm fetal development, contraindicated during pregnancy

  • Cancer history: Avoid in individuals with active malignancy due to GH/IGF-1 axis stimulation

  • Diabetes or insulin resistance: Monitor glucose levels closely

  • Drug interactions: Avoid concurrent use with GH or IGF-1 analogs unless clinically justified

Why Tesamorelin Should Be On Your Radar

  • Precision GHRH analog: Tesamorelin isn’t just another GH secretagogue, it’s a bioengineered 44-amino acid peptide that mimics endogenous GHRH with enhanced stability and potency.

  • VAT targeting: It’s one of the few peptides clinically proven to selectively reduce visceral fat, not just subcutaneous fluff. That makes it a standout for metabolic optimization and body composition.

  • Feedback-preserving: Unlike exogenous GH, tesamorelin stimulates natural GH release without shutting down the axis. That means safer long-term modulation and tighter hormonal control.

  • IGF-1 elevation without chaos: You get the anabolic and lipolytic benefits of IGF-1 without the supraphysiologic GH spikes that can trigger insulin resistance or edema.

  • Neurocognitive edge: Early data suggests it may support hippocampal function and memory, especially in populations with metabolic dysfunction, an emerging differentiator.t this product is about. What’s it made of? How was it made? What are ways to enjoy it?

Tesamorelin is not just another GH secretagogue, it’s a precision-engineered GHRH analogue that targets visceral fat, preserves hormonal balance, and may offer neuroprotective benefits.

Molecular Engineering

  • 44-amino acid GHRH analogue with N-terminal modifications

  • These tweaks enhance enzymatic stability, extend half-life, and optimize receptor binding

  • Unlike natural GHRH, tesamorelin resists degradation and maintains potency over time

Targeted Visceral Fat Reduction

  • Tesamorelin selectively reduces visceral adipose tissue (VAT)—the deep, inflammatory fat around organs

  • Clinical studies show 15-20% VAT reduction over 6 months, with minimal impact on subcutaneous fat

  • This selectivity is due to higher GH receptor density in visceral fat cells, making them more responsive to GH pulses

Feedback-Preserving GH Modulation

  • Stimulates endogenous GH release via pituitary GHRH receptors

  • Preserves natural feedback loops, unlike exogenous GH which suppresses native production

  • Elevates IGF-1 without overshooting physiological GH levels, reducing risk of insulin resistance

Emerging Neurocognitive Benefits

  • Tesamorelin has shown promise in improving cognitive function in HIV-positive individuals with abdominal obesity

  • May support hippocampal integrity and working memory, likely via IGF-1 and GH-mediated neurogenesis

Common Side Effects

  • Injection site reactions: Redness, swelling, or discomfort

  • Joint pain or stiffness: Especially in knees, wrists, or fingers

  • Muscle aches: Mild soreness or fatigue

  • Peripheral edema: Fluid retention in hands, feet, or face

  • Tingling or numbness: Often in fingers (carpal tunnel-like symptoms)

Less Common but Notable

  • Elevated fasting glucose: Tesamorelin may slightly raise blood sugar in some individuals

  • Headache, dizziness, or palpitations: Usually transient

  • Nervousness or sleep disturbances: Rare but reported

  • Hypersensitivity reactions: Rash, hives, or swelling, discontinue if observed

Cautionary Notes

  • Pregnancy: Tesamorelin can harm fetal development, contraindicated during pregnancy

  • Cancer history: Avoid in individuals with active malignancy due to GH/IGF-1 axis stimulation

  • Diabetes or insulin resistance: Monitor glucose levels closely

  • Drug interactions: Avoid concurrent use with GH or IGF-1 analogs unless clinically justified

Why Tesamorelin Should Be On Your Radar

  • Precision GHRH analog: Tesamorelin isn’t just another GH secretagogue, it’s a bioengineered 44-amino acid peptide that mimics endogenous GHRH with enhanced stability and potency.

  • VAT targeting: It’s one of the few peptides clinically proven to selectively reduce visceral fat, not just subcutaneous fluff. That makes it a standout for metabolic optimization and body composition.

  • Feedback-preserving: Unlike exogenous GH, tesamorelin stimulates natural GH release without shutting down the axis. That means safer long-term modulation and tighter hormonal control.

  • IGF-1 elevation without chaos: You get the anabolic and lipolytic benefits of IGF-1 without the supraphysiologic GH spikes that can trigger insulin resistance or edema.

  • Neurocognitive edge: Early data suggests it may support hippocampal function and memory, especially in populations with metabolic dysfunction, an emerging differentiator.t this product is about. What’s it made of? How was it made? What are ways to enjoy it?

You may also be interested in...

Reta Reta Reta Reta
Reta
from $50.00

Mechanism of Action: Triple Receptor Agonist

Retatrutide is a synthetic peptide that activates three key metabolic receptors:

  • GLP-1 (Glucagon-Like Peptide-1) → Enhances insulin secretion, suppresses appetite, delays gastric emptying

  • GIP (Glucose-Dependent Insulinotropic Polypeptide) → Boosts insulin response, improves insulin sensitivity, may support lipid metabolism

  • Glucagon Receptor (GCGR) → Elevates energy expenditure, promotes fat oxidation, and may reduce liver fat

This triple agonist profile delivers synergistic effects on glycemic control, fat loss, and metabolic health, making Retatrutide the most advanced incretin-based peptide in development.

Disposition:

  • Structure: Acylated peptide with a fatty diacid moiety → extends half-life via albumin binding

  • Half-life: ~6 days → supports once-weekly dosing

  • Administration: Subcutaneous injection

Clinical Data Highlights:

  • Weight Loss: Up to 24.2% body weight reduction in phase 2 trials, highest recorded among incretin-based therapies

  • Glycemic Control: HbA1c reductions of 2.0–2.5% in type 2 diabetes patients

  • Lipid Profile: Significant drops in triglycerides, LDL-C, and liver fat content

  • Insulin Sensitivity: Improved HOMA-IR and fasting insulin levels

  • Energy Expenditure: Increased basal metabolic rate and fat oxidation via glucagon receptor activation

  • For a full breakdown of Retatrutide clinical trials and results you can click the link.

Why Retatrutide is Exciting:

  • Triple Mechanism = Broader Impact: Targets fat loss, insulin sensitivity, and energy balance simultaneously

  • Once-Weekly Dosing: High compliance, low friction

  • Backed by Data: Clinically validated, outperforming single and dual agonists in key metrics

  • Ideal for Advanced Protocols: Perfect for those looking for the best potential results

  • Outperforms Semaglutide & Tirzepatide for total weight lost in trials

  • Available in Canada with fast domestic shipping

Most common side effects:

  • Nausea, diarrhea & constipation

  • Side effects are dose dependent and typically subside the longer the drug is used

  • You can check out the full guide on managing Retatrutide side effects by clicking on the link.

Bottom line:

The science behind Retatrutide represents a breakthrough in obesity pharmacotherapy through its unique triple-receptor mechanism.

By simultaneously activating GIP, GLP-1, and glucagon receptors, this powerful peptide produces synergistic metabolic effects that exceed what single or dual agonist medications can achieve.

The glucagon receptor component increases energy expenditure and fat oxidation, while GLP-1 suppresses appetite and slows gastric emptying, and GIP enhances insulin secretion while potentially reducing nausea.

This coordinated activation of three complementary pathways explains the unprecedented 24.2% average weight loss observed in Phase 2 trials.

Rather than targeting obesity through a single mechanism, this 3-way agonist addresses the complex hormonal and metabolic networks that regulate body weight, treating obesity as the multifaceted metabolic disease it truly is.

Peer-Reviewed Research Citations

1. Primary Phase 2 Obesity Trial: Jastreboff AM, Aronne LJ, Ahmad NN, et al. Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial. N Engl J Med. 2023;389(6):514-526. doi:10.1056/NEJMoa2301972

PubMed:https://pubmed.ncbi.nlm.nih.gov/37366315/

This landmark study demonstrated 24.2% mean weight loss at 48 weeks with the 12mg dose in 338 adults with obesity, establishing retatrutide as the most effective obesity medication tested to date.

2. Phase 2 Type 2 Diabetes Trial: Rosenstock J, Frias J, Jastreboff AM, et al. Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA. Lancet. 2023;402(10401):529-544. doi:10.1016/S0140-6736(23)01053-X

PubMed:https://pubmed.ncbi.nlm.nih.gov/37385280/

This trial evaluated retatrutide in 281 participants with type 2 diabetes, showing up to 16.94% weight loss and significant HbA1c reductions with favorable safety profile comparable to other GLP-1 based therapies.

3. Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Substudy: Loomba R, Hartman ML, Lawitz EJ, et al. Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial. Nat Med. 2024;30(6):1753-1760. doi:10.1038/s41591-024-02970-5

PubMed:https://pubmed.ncbi.nlm.nih.gov/38858523/

This substudy demonstrated that retatrutide reduced liver fat by 81-82% at the 8mg and 12mg doses over 24 weeks, providing evidence of retatrutide’s multi-system metabolic benefits beyond weight loss.

KLOW KLOW
KLOW
$130.00

What’s in KLOW?

  • GHK-Cu (50 mg)
    Drives collagen synthesis, angiogenesis, and gene-level repair. Enhances skin texture, elasticity, and wound healing.

  • BPC-157 (10 mg)
    Accelerates tendon, ligament, and gut repair. Promotes angiogenesis and modulates nitric oxide and growth factor signaling.

  • TB-500 (10 mg)
    Enhances cell migration, reduces fibrosis, and supports muscle, nerve, and epithelial regeneration.

  • KPV (10 mg)
    A fragment of α-MSH that potently inhibits NF-κB and pro-inflammatory cytokines like TNF-α and IL-6. Supports gut lining integrity and may reduce autoimmune flare-ups, dermatitis, and systemic inflammation.

Mechanism of Action

KLOW works by combining four synergistic peptides that act on complementary pathways:

  • Tissue repair: BPC-157 and TB-500 promote angiogenesis, fibroblast activation, and ECM remodeling

  • Skin regeneration: GHK-Cu stimulates collagen, elastin, and antioxidant enzymes

  • Inflammation control: KPV suppresses inflammatory signaling and may reduce injection site irritation

  • Immune modulation: The stack balances immune activity without overstimulation, supporting recovery from injury, stress, or inflammation

Why It’s Used

KLOW is favored for its broad-spectrum regenerative potential, especially in cases involving:

  • Chronic inflammation

  • Skin aging or scarring

  • Muscle, tendon, or joint recovery

  • Gut permeability or inflammatory bowel symptoms

  • Immune-mediated conditions (e.g., dermatitis, allergic asthma)

Selank Selank
Selank
$40.00

Selank is a synthetic peptide made of seven amino acids, developed in Russia. It’s based on tuftsin, a natural peptide your immune system already produces. Researchers added three extra amino acids to the end so it lasts longer in the body before getting broken down.

How It Works

Selank doesn’t just target one system. It hits several:

  • GABA receptors – modulates the same receptor family as anti-anxiety drugs, but without the sedation, brain fog, or dependence seen with benzos

  • Serotonin – stabilizes serotonin levels and its metabolites in the brain

  • Dopamine and norepinephrine – influences turnover of both in key brain regions

  • BDNF – boosts production of brain-derived neurotrophic factor, a protein tied to learning, memory, and neuron health

  • Enkephalins – blocks the enzymes that break down your body’s natural painkillers, raising their levels

  • Immune function – affects 50+ genes related to inflammation and immune response through its tuftsin backbone

Why Researchers Care

  • Anxiolytic effects without sedation or cognitive impairment

  • No tolerance or withdrawal in preclinical studies

  • Actually appears to sharpen cognition rather than dull it

  • Dual action as both a nootropic and anxiolytic is a rare combo

  • Broad gene expression changes (36 genes in the hippocampus within one hour)

Bacteriostatic Sterile Water – 30 mL Bacteriostatic Sterile Water – 30 mL
Bacteriostatic Sterile Water – 30 mL
$25.00

Bacteriostatic Sterile Water is sterile water that contains a small amount of a preservative which inhibits bacterial growth. Commonly used to dilute or reconstitute peptides for injection.

Shop All